177 related articles for article (PubMed ID: 20086161)
1. Pharmacokinetics of liposomal amphotericin B in pleural fluid.
Moriyama B; Torabi-Parizi P; Pratt AK; Henning SA; Pennick G; Shea YR; Roy Chowdhuri S; Rinaldi MG; Barrett AJ; Walsh TJ
Antimicrob Agents Chemother; 2010 Apr; 54(4):1633-5. PubMed ID: 20086161
[TBL] [Abstract][Full Text] [Related]
2. Penetration of amphotericin B lipid formulations into pleural effusion.
Weiler S; Bellmann-Weiler R; Joannidis M; Bellmann R
Antimicrob Agents Chemother; 2007 Nov; 51(11):4211-3. PubMed ID: 17785511
[TBL] [Abstract][Full Text] [Related]
3. Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.
Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
Antimicrob Agents Chemother; 2002 Mar; 46(3):834-40. PubMed ID: 11850269
[TBL] [Abstract][Full Text] [Related]
4. Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia.
Salonen JH
Acta Biomed; 2006; 77 Suppl 2():28-31. PubMed ID: 16918065
[TBL] [Abstract][Full Text] [Related]
5. Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.
Purcell IF; Corris PA
Thorax; 1995 Dec; 50(12):1321-3. PubMed ID: 8553311
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary mucormycosis: benefit of aerosol amphotericin B?].
Furco A; Mouchet B; Carbonnelle M; Vallerand H
Rev Mal Respir; 2001 Jun; 18(3):309-13. PubMed ID: 11468594
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis.
Lewis RE; Albert ND; Liao G; Hou J; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2010 Mar; 54(3):1298-304. PubMed ID: 20038620
[TBL] [Abstract][Full Text] [Related]
8. Cunninghamella bertholletiae infection in a bone marrow transplant patient: amphotericin lung penetration, MIC determinations, and review of the literature.
Garey KW; Pendland SL; Huynh VT; Bunch TH; Jensen GM; Pursell KJ
Pharmacotherapy; 2001 Jul; 21(7):855-60. PubMed ID: 11444582
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant intrapleural amphotericin B therapy for pulmonary mucormycosis in a cardiac allograft recipient.
Kfoury AG; Smith JC; Farhoud HH; Terreros DA; Stringham JC; Taylor DO; Renlund DG
Clin Transplant; 1997 Dec; 11(6):608-12. PubMed ID: 9408694
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
[TBL] [Abstract][Full Text] [Related]
11. Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety.
Monforte V; Ussetti P; López R; Gavaldà J; Bravo C; de Pablo A; Pou L; Pahissa A; Morell F; Román A
J Heart Lung Transplant; 2009 Feb; 28(2):170-5. PubMed ID: 19201343
[TBL] [Abstract][Full Text] [Related]
12. Surgical resection and liposomal amphotericin B to treat cavitary pulmonary zygomycosis in a patient with diabetes.
Hua-Ping Z; Jian L; Jing-Bin H; Jie G; Guo-Xin M; Yan-Hong J; Li-Xin X
Respir Care; 2011 Nov; 56(11):1837-9. PubMed ID: 21605482
[TBL] [Abstract][Full Text] [Related]
13. Management of Aspergillus pleural empyema with combined systemic and intrapleural antifungal therapy in a pediatric patient: Case report.
Almuhareb A; Habib Z
J Infect Public Health; 2018; 11(2):280-282. PubMed ID: 28545901
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China].
Yang YM; Fang BM; Xu XM; Fang F; Pan MM; Zhong XF; Sun TY
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):572-6. PubMed ID: 24252732
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis.
Lestner JM; Howard SJ; Goodwin J; Gregson L; Majithiya J; Walsh TJ; Jensen GM; Hope WW
Antimicrob Agents Chemother; 2010 Aug; 54(8):3432-41. PubMed ID: 20439615
[TBL] [Abstract][Full Text] [Related]
16. Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats.
Boswell GW; Bekersky I; Buell D; Hiles R; Walsh TJ
Antimicrob Agents Chemother; 1998 Feb; 42(2):263-8. PubMed ID: 9527770
[TBL] [Abstract][Full Text] [Related]
17. Current controversies in treating invasive zygomycosis.
Cornely OA
J Pediatr Hematol Oncol; 2010 Mar; 32(2):83-4. PubMed ID: 20090559
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of liposomal amphotericin B in neutropenic cancer patients.
Eldem T; Arican-Cellat N; Agabeyoglu I; Akova M; Kansu E
Int J Pharm; 2001 Feb; 213(1-2):153-61. PubMed ID: 11165103
[TBL] [Abstract][Full Text] [Related]
19. Liposomal amphotericin B pharmacokinetics in a patient treated with extracorporeal membrane oxygenation.
Foulquier JB; Berneau P; Frérou A; Verdier MC; Saint-Marcoux F; Petitcollin A; Tron C; Bellissant E; Lemaitre F
Med Mal Infect; 2019 Feb; 49(1):69-71. PubMed ID: 30466763
[No Abstract] [Full Text] [Related]
20. Treatment of deep mycoses with liposomal amphotericin B.
Berenguer J; Muñoz P; Parras F; Fernández-Baca V; Hernández-Sampelayo T; Bouza E
Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):504-7. PubMed ID: 7957273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
